Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis

International Journal of Food Sciences and Nutrition

Volumn 66, Issue 5, 2015, Pages 569-573

  Hirotani, Yoshihiko ^a   Ozaki, Nozomi ^a   Tsuji, Yoshihiro ^a   Urashima, Yoko ^a   Myotoku, Michiaki ^a  

^a OSAKA OHTANI UNIVERSITY   (Japan)

Author keywords

Eicosapentaenoic acid; High fat diet; Non alcoholic fatty liver disease; Obesity; Oxidative stress

Indexed keywords

MUS;

ANTIOXIDANT; CHOLESTEROL; ICOSAPENTAENOIC ACID; TRIACYLGLYCEROL;

ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; DIETARY SUPPLEMENT; DRUG EFFECTS; DYSLIPIDEMIAS; LIPID DIET; LIPID METABOLISM; LIVER; MALE; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OXIDATIVE STRESS;

ANIMALS; ANTIOXIDANTS; CHOLESTEROL; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DYSLIPIDEMIAS; EICOSAPENTAENOIC ACID; LIPID METABOLISM; LIVER; MALE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OXIDATIVE STRESS; TRIGLYCERIDES;

EID: 84938056278     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2015.1042848     Document Type: Article

References (25)

1. Abete I, Goyenechea E, Zulet MA, Martńez JA. 2011. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis 21:B1-B15.
2. Assy N. 2011. Nutritional recommendations for patients with nonalcoholic fatty liver diseases. World J Gastroenterol 17:3375-3376.
3. Baloseanu CL, Streba CT, Vere CC, Comanescu V, Rogoveanu I. 2012. Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD). Rom J Morphol Embryol 53:609-614.
4. Chapkin RS, Kim W, Lupton JR, McMurray DN. 2009. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 81: 187-191.
5. Di Minno MND, Russolillo A, Lupoli R, Ambrosino P, Di Minno A, Tarantino G. 2012. Omega-3 fatty acids for the treatment of nonalcoholic fatty liver disease. World J Gastroenterol 18:5839-5847.
6. Espinosa A, Valenzuela R, González-Manãń D, D'Espessailles A, Guillermo Gormaz J, Barrera C, Tapia G. 2013. Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content. Arch Latinoam Nutr 63:29-36.
7. Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509.
8. González-Périz A, Horrillo R, Ferré N, Gronert K, Dong B, Morán-Salvador E, Titos E, et al. 2009. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 23:1946-1957.
9. Haimeur A, Ulmann L, Mimouni V, Guéno F, Pineau-Vincent F, Meskini N, Tremblin G. 2012. The role of Odontella aurita, a marine diatom rich in EPA, as a dietary supplement in dyslipidemia, platelet function and oxidative stress in high-fat fed rats. Lipids Health Dis 11:147-159.
10. Jump DB. 2008. N3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 19:242-247.
11. Kalupahana NS, Claycombe K, Newman SJ, Stewart T, Siriwardhana N, Matthan N, Lichtenstein AH, Moustaid-Moussa N. 2010. Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr 140:1915-1922.
12. Oliveira CP, Coelho AM, Barbeiro HV, Lima VM, Soriano F, Ribeiro C, Molan NA, et al. 2006. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz J Med Biol Res 39:189-194.
13. Perez-Martinez P, Perez-Jimenez F, Lopez-Miranda J. 2010. n3 PUFA and lipotoxicity. Biochim Biophys Acta 1801:362-366.
14. Pérez-Matute P, Pérez-Echarri N, Martńez JA, Marti A, Moreno-Aliaga MJ. 2007. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br J Nutr 97:389-398.
15. Popescu LA, Vrgolici B, Lixandru D, Miricescu D, Condruţ E, Timnea O, Ranetti AE, et al. 2013. Effect of diet and omega-3 fatty acids in NAFLD. Rom J Morphol Embryol 54:785-790.
16. Quiroga AD, Li L, Trötzmüller M, Nelson R, Proctor SD, Köfeler H, Lehner R. 2012. Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia. Hepatology 56: 2188-2198.
17. Robbez Masson V, Lucas A, Gueugneau AM, Macaire JP, Paul JL, Grynberg A, Rousseau D. 2008. Long-chain (n-3) polyunsaturated fatty acids prevent metabolic and vascular disorders in fructose-fed rats. J Nutr 138:1915-1922.
18. Saraswathi V, Morrow JD, Hasty AH. 2009. Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR/mice. J Nutr 139:2380-2386.
19. Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P. 2011. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Clin Nutr 30:6-19.
20. Shirouchi B, Nagao K, Inoue N, Ohkubo T, Hibino H, Yanagita T. 2007. Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats. J Agric Food Chem 55:7170-7176.
21. Szalman K, Bancu L, Sin A. 2013. Correlations between anthropometric and serologic elements of metabolic syndrome and histopathologic features of nonalcoholic fatty liver disease. Rom J Morphol Embryol 54:173-178.
22. Tillander V, Bjørndal B, Burri L, Bohov P, Skorve J, Berge RK, Alexson SE. 2014. Fish oil and krill oil supplementations differentially regulate lipid catabolic and synthetic pathways in mice. Nutr Metab (Lond) 11:20.
23. Valenzuela R, Espinosa A, González-Manãń D, D'Espessailles A, Fernández V, Videla LA, Tapia G. 2012. N3 long-chain polyunsaturated fatty acid supplementation significantly reduces liver oxidative stress in high fat induced steatosis. PLoS One 7: 1-8.
24. Valenzuela R, Videla LA. 2011. The importance of the long-chain polyunsaturated fatty acid n6/n3 ratio in development of nonalcoholic fatty liver associated with obesity. Food Funct 2: 644-648.
25. Yanagita T, Nagao K. 2008. Functional lipids and the prevention of the metabolic syndrome. Asia Pac J Clin Nutr 17:189-191.